JP2024530325A5 - - Google Patents
Info
- Publication number
- JP2024530325A5 JP2024530325A5 JP2024513383A JP2024513383A JP2024530325A5 JP 2024530325 A5 JP2024530325 A5 JP 2024530325A5 JP 2024513383 A JP2024513383 A JP 2024513383A JP 2024513383 A JP2024513383 A JP 2024513383A JP 2024530325 A5 JP2024530325 A5 JP 2024530325A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/115621 | 2021-08-31 | ||
| CN2021115621 | 2021-08-31 | ||
| PCT/CN2022/115536 WO2023030258A1 (en) | 2021-08-31 | 2022-08-29 | Anti-4-1bb nanobodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530325A JP2024530325A (ja) | 2024-08-16 |
| JP2024530325A5 true JP2024530325A5 (cg-RX-API-DMAC7.html) | 2025-09-08 |
Family
ID=85410851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513383A Pending JP2024530325A (ja) | 2021-08-31 | 2022-08-29 | 抗4-1bbナノボディ |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240383993A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4396234A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024530325A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240049829A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118176211A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022336889A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3230481A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311144A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024002720A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023030258A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024530325A (ja) | 2021-08-31 | 2024-08-16 | ラノバ メディシンズ リミテッド | 抗4-1bbナノボディ |
| AU2024229974A1 (en) * | 2023-02-28 | 2025-09-11 | LaNova Medicines Limited | Ceacam5-dependent 4-1bb-agonistic bispecific antibodies |
| WO2025214249A1 (en) * | 2024-04-12 | 2025-10-16 | Suzhou Biomissile Pharmaceuticals Co., Ltd. | Anti-4-bb single domain antibodies, bispecific antibodies and uses thereof |
| WO2026075820A1 (en) * | 2024-10-03 | 2026-04-09 | Modernatx, Inc. | 4-1bb binding molecules, nucleic acids encoding same, and methods of use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2461546B (en) | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| CN104829730A (zh) | 2015-04-14 | 2015-08-12 | 苏静 | 一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用 |
| IL304871A (en) * | 2016-01-11 | 2023-10-01 | Inhibrx Inc | Multispecific and multivalent binding fusion proteins - 41BB, preparations containing them and their uses |
| US10174122B2 (en) * | 2017-01-06 | 2019-01-08 | Eutilex Co., Ltd. | Anti-human 4-1BB antibodies and uses thereof |
| CA3082297A1 (en) * | 2017-11-13 | 2019-05-16 | Crescendo Biologics Limited | Molecules that bind to cd137 and psma |
| JP7357616B2 (ja) * | 2017-12-05 | 2023-10-06 | 中外製薬株式会社 | Cd3およびcd137に結合する改変された抗体可変領域を含む抗原結合分子 |
| TW201932491A (zh) * | 2018-01-22 | 2019-08-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抗4-1bb抗體、其抗原結合片段及其醫藥用途 |
| CN108659131B (zh) | 2018-05-28 | 2021-09-14 | 长春力太生物技术有限公司 | 一种抗ceacam-5的单域抗体及其应用 |
| TW202035447A (zh) * | 2018-07-04 | 2020-10-01 | 瑞士商赫孚孟拉羅股份公司 | 新穎雙特異性促效性4-1bb抗原結合分子 |
| CN112646031B (zh) * | 2019-10-10 | 2021-12-07 | 天境生物科技(上海)有限公司 | 抗4-1bb纳米抗体及其用途 |
| CN117355540A (zh) | 2021-05-21 | 2024-01-05 | 百济神州有限公司 | 抗cd137抗体和使用方法 |
| JP2024530325A (ja) | 2021-08-31 | 2024-08-16 | ラノバ メディシンズ リミテッド | 抗4-1bbナノボディ |
-
2022
- 2022-08-29 JP JP2024513383A patent/JP2024530325A/ja active Pending
- 2022-08-29 IL IL311144A patent/IL311144A/en unknown
- 2022-08-29 US US18/687,277 patent/US20240383993A1/en active Pending
- 2022-08-29 CA CA3230481A patent/CA3230481A1/en active Pending
- 2022-08-29 MX MX2024002720A patent/MX2024002720A/es unknown
- 2022-08-29 AU AU2022336889A patent/AU2022336889A1/en active Pending
- 2022-08-29 WO PCT/CN2022/115536 patent/WO2023030258A1/en not_active Ceased
- 2022-08-29 CN CN202280070221.9A patent/CN118176211A/zh active Pending
- 2022-08-29 KR KR1020247009916A patent/KR20240049829A/ko active Pending
- 2022-08-29 EP EP22863394.7A patent/EP4396234A4/en active Pending
-
2025
- 2025-05-02 US US19/197,775 patent/US12692318B2/en active Active